What's breaking now, across thousands of outlets.
The death of a worker from a Russian lab that researches plague has prompted questions about the disease.
We haven't written up this one. BBC News has the full story — the link below goes straight to it.
A new analysis found that the diabetes medication orforglipron (Foundayo), an oral GLP-1, helped women lose weight regardless of their menopausal status.
Option Care Health, the country's largest independent provider of at-home and alternate site infusion services, would go private in the deal, which is expected to close in the first half of 2027.
Short-read RNA sequencing reporting the modifications that alter protein output is starting to make epitranscriptomics indispensable for patient selection in precision medicines.
MOSCOW/LONDON — A laboratory worker at a plague research institute in Siberia fell ill and died in undisclosed circumstances on October 2, prompting authorities to quarantine about 200 people and…
Ndubuisi Francis in Abuja The Medical Director of the Federal Medical Centre (FMC), Yenagoa, Bayelsa State, Dr. James Enimi Omietimi, has raised concerns over the non-release of the centre’s 2025
